Cytomegalovirus genotypes gB1 and gH1 Are the most predominant genotypes among renal transplant recipients in Kuwait

Transplantation Proceedings

Volumn 43, Issue 5, 2011, Pages 1634-1637

  Madi, N ^a   Al Nakib, W ^a   Pacsa, A ^a   Saeed, T ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; DACLIZUMAB; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL THERAPY; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIGESTIVE SYSTEM ULCER; DISEASE SEVERITY; DNA EXTRACTION; FEMALE; FEVER; GENOTYPE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HYPERTRANSAMINASEMIA; IMMUNOCOMPROMISED PATIENT; KIDNEY TRANSPLANTATION; KUWAIT; LEUKOPENIA; MALAISE; MALE; NONHUMAN; OUTCOME ASSESSMENT; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOCYTOPENIA; VIRUS LOAD;

BASE SEQUENCE; DNA PRIMERS; GENOTYPE; HUMANS; KIDNEY TRANSPLANTATION; KUWAIT;

EID: 79959475533     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.02.053     Document Type: Article

References (13)

1. R.S. Cvetkovic, and K. Wellington Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients Drugs 65 2005 859
2. S.S. Kanj, A.I. Sharara, and P.A. Clavien Cytomegalovirus infection following liver transplantation: review of the literature Clin Infect Dis 22 1996 537
3. L. Rasmussem, and A.Winters M. Geissler Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus JID 187 2003 809
4. P.C. Woo, C.Y. Lo, and S.K. Lo Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease Clin Diagn Lab Immunol 4 1997 515
5. P. Ljungman, and P.A. Stanly Workshop on cytomegalovirus disease: definitions, clinical severity scores and new syndromes Scand J Infect Dis 99 suppl 1995 187
6. C. Vogelberg, U. Meyer-Knig, and F.T. Hufert Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients J Med Virol 50 1996 31
7. S. Chou Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus J Infect Dis 166 1992 604
8. N. Madi, W. Al-Nakib, and A.S. Mustafa Detection and monitoring of cytomegalovirus infection in renal transplant patients by quantitative real-time PCR Med Princ Pract 16 2007 268
9. A. Humar, D. Kumar, and C. Gilbert Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease J Infect Dis 188 2003 581
10. A. Coaquette, A. Bourgeois, and C. Dirand Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients Clin Infect Dis 39 2004 155
11. B.C. Fries, S. Chou, and M. Boeckh Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients J Infect Dis 169 1994 769
12. H.R. Rosen, C.L. Corless, and J. Rabkin Association of cytomegalovirus genotype with graft rejection after liver transplantation Transplantation 66 1998 1627
13. B. Torok-Storb, M. Boeckh, and C. Hoy Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation Blood 90 1997 2097